Literature DB >> 2411889

Diagnosis and management of large toxic multinodular goiters.

J I Hamburger, S W Hamburger.   

Abstract

Toxic multinodular goiters, estimated weight 100 g or more, occurred in 35 patients between 1961 and 1984. All but two were older than 50; 32 were females. Twenty had goiters of 100-130 g; four of 140-200 g; and 11 were massive. Radioiodine uptakes were 30% or less for 22. Seven of 17 with both T4 and T3 data had T4 toxicosis. Thirty-two patients received radioiodine therapy, delivering 200 microCi per gram when possible. Doses were 25-30 mCi for 17 patients; 50-100 mCi for 12 patients, and 150-200 mCi for three patients. Hyperthyroidism was eliminated with one dose in 25 patients (78%); five patients required two doses. Twenty-two patients were euthyroid after radioiodine; 25 of 28 had persistent goiters. Two patients were treated successfully surgically. One refused surgery and radioiodine, and has been maintained on antithyroid drugs for 10 yr. Two patients died within a few months of an unsuccessful initial dose of radioiodine. Large dose radioiodine therapy is simple, safe, and effective for most patients with large toxic multinodular goiters.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411889

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  The natural history of euthyroid multinodular goitre.

Authors:  J W Elte; J K Bussemaker; A Haak
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

Review 2.  Evidence-based management of toxic multinodular goiter (Plummer's Disease).

Authors:  John R Porterfield; Geoffrey B Thompson; David R Farley; Clive S Grant; Melanie L Richards
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

3.  Reproducibility of radioactive iodine uptake (RAIU) measurements.

Authors:  Matthieu Pelletier-Galarneau; Patrick Martineau; Ran Klein; Matthew Henderson; Lionel S Zuckier
Journal:  J Appl Clin Med Phys       Date:  2017-11-22       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.